Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
31 January 2018 Photo UFS Archive
Young squad did it for Shimlas
The 11th season of this popular rugby competition started on Monday 29 January, with the scoreboard favouring Shimlas on 19 points versus the 17 points of Tuks.

The head coach of the Shimla rugby team is confident that the skills level of the players will stand them in good stead for the upcoming Varsity Cup.

The 11th season of this popular rugby competition started on Monday 29 January, with the scoreboard favouring Shimlas on 19 points versus the 17 points of Tuks. The Shimlas faced last year’s champions, Tuks, in Pretoria. 

The rest of the 2018 Varsity Cup season will have the Shimlas playing on 5 February against Maties (away); 12 February against Wits (home); 19 February against Ikeys (away); 26 February against UJ (home); 12 March against NWU (away); 19 March against Madibaz (home); and 26 March against CUT (home).

Head coach, Hendro Scholtz, believes his players have the ability to play at a high tempo for 80 minutes.

“We don’t have the biggest boys around, so we rely on our speed and ability to throw the ball around. You can focus on your defence as much as you like, but tries will be scored. You simply have to ensure that you outscore your opponents,” said Hendro.

With up to nine players from last year’s squad not available again in 2018, the Shimlas are entering the competition with a very young and inexperienced team. According to Hendro, the big dropout since last year is due to a number of reasons, such as students who finished their studies.

“We will have to battle this Varsity Cup with a very young team, of which 10 players were still U19 last year. We faced the University of Johannesburg in a warm-up match, and for many of them it was an eye-opener. The speed and intensity is at a higher level than they were used to at U19 level,” said Hendro, a former Shimla himself.

He will be assisted by Melusi Mthetwa and Jaco Swanepoel.

* The Shimla squad:
Backs: Sango Xamlashe, Carel-Jan Coetzee, Kurt Eybers, Dian Badenhorst, Frank van Heerden, Francois Agenbach, Arrie Pretorius, Rewan Kruger, Zinedine Booysen, Nakkie Naudé, Lubabalo Dobela, William Eybers, Francois Pretorius, Aya Oliphant, Charl Pretorius, Ruan Henning, Sechaba Matsoele, Athi Halom, Jarik van der Walt, Tiaan Schutte, Marnus Boshoff. Forwards: Johan Kotze (captain), Louis Cloete, Nardus Erasmus, JC Janse van Vuuren, Ruan Roelofse, Magau Mabokela, Jano Botha, Helgard Meyer, Wentzel Vorster, Hanno Snyman, Marco van der Merwe, Merwyn Roos, Raymond Woest, Sibabalo Qoma, Nathan Jordan, Benji Jan van Vuuren, Menzi Nhlabathi, Janco Cloete, Kobus Lombaard, Bertie de Bod, Rholane Ncubuka, Henk Pretorius.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept